Gene editing is transforming cancer research and therapy with the ability to make precise alterations to the genetic code of cells. The topic "Gene Editing" highlights the recent breakthroughs in technologies like CRISPR-Cas9 that can help researchers target specific genes that contribute to tumor development and progression.
Through editing or fixing genetic mutations, scientists are able to create new therapies that target cancer at its underlying cause. Gene editing can be used to make more potent immunotherapies, tailor-make treatments, and investigate cancer biology in model systems. For instance, CRISPR can be employed to design immune cells that recognize and kill cancer cells more effectively, making therapies such as CAR T-cell therapy more effective.
The session also discusses the ethical implications, safety concerns, and regulatory implications of gene editing in cancer. Scientists are trying to enhance accuracy, minimize off-target effects, and make treatments both safe and effective for patients.
Participants will have a clear grasp of gene-editing techniques, their clinical use in cancer treatment, and the potential in the future to revolutionize oncology. This session highlights how gene editing is opening the door to more targeted, personalized, and potent cancer treatments, providing new hope to patients around the globe."
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
